Jonathan Violin
Director · CRESCENT BIOPHARMA, INC.
Individual
- 2025
- Jun 3, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jonathan Violin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Marino Garcia - $27.96M in DNTH purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $20.00M in CBIO purchases and sales in the last 12 months
- Simrat Randhawa - $15.00M in DNTH purchases and sales in the last 12 months
- Ryan Savitz - $14.29M in DNTH purchases and sales in the last 12 months
- Edward Carr - $5.59M in DNTH purchases and sales in the last 12 months
- Adam M. Veness - $4.63M in DNTH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jonathan Violin?
Jonathan Violin is a corporate insider, tracked as Director of CRESCENT BIOPHARMA, INC. (CBIO). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Jonathan Violin last file a Form 4?
The most recent primary Form 4 on record is dated 3 June 2026, one of 4 filings going back to 2025.
